NCT02745769 - A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents | Biotech Hunter

Enrollment

23

Participants

Timeline

Start Date

October 21, 2016

Primary Completion Date

November 5, 2018

Study Completion Date

January 22, 2019

Conditions

Advanced CancerColorectal CancerMantle Cell Lymphoma

Interventions

DRUG

Ramucirumab

Administered IV

DRUG

Merestinib

Administered orally

DRUG

Abemaciclib

Administered orally

Trial Locations (5)

13385

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Marseille

35249

UAB Comprehensive Cancer Center, Birmingham

69373

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lyon

77030

University of Texas MD Anderson Cancer Center, Houston

SE1 9RT

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London